CUAMC
China Universal Asset Management Company’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.2K | Buy |
39,808
+286
| +0.7% | +$282 | ﹤0.01% | 432 |
|
|
2025
Q1 | $56.9K | Sell |
39,522
-2,257
| -5% | -$3.25K | 0.01% | 411 |
|
|
2024
Q4 | $91.9K | Buy |
+41,779
| New | +$91.9K | 0.01% | 403 |
|
|
2023
Q4 | – | Sell |
-2,748
| Closed | -$2.69K | – | 445 |
|
|
2023
Q3 | $2.69K | Buy |
2,748
+1,507
| +121% | +$1.48K | ﹤0.01% | 421 |
|
|
2023
Q2 | $1.73K | Buy |
1,241
+203
| +20% | +$282 | ﹤0.01% | 435 |
|
|
2023
Q1 | $1.65K | Buy |
1,038
+289
| +39% | +$459 | ﹤0.01% | 438 |
|
|
2022
Q4 | $4.67K | Buy |
749
+126
| +20% | +$785 | ﹤0.01% | 307 |
|
|
2022
Q3 | $4K | Buy |
+623
| New | +$4K | ﹤0.01% | 295 |
|